India signs deal with domestic vaccine maker Biological-E for 300 million doses
BENGALURU (Reuters) -India s government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million), the first such order for unapproved shots. Biological E., which also has a separate deal to produce about 600 million doses of Johnson & Johnson s COVID-19 shot annually, said on Tuesday it entered into a licensing agreement with Providence Therapeut…
12 hours ago|Los Angeles, United States